ArticleCureus2026
Excellent Response to Oral Isotretinoin in a Pediatric Patient With Dissecting Cellulitis of the Scalp.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dissecting cellulitis of the scalp (DCS) is a rare, chronic inflammatory scalp disorder that is characterized by painful, recurrent nodules, abscesses, fistulas, and sinus tracts that can lead to scarring alopecia. We present the case of an 11-year-old Black female with painful, pruritic scalp nodules and hair loss of several months' duration. The patient's clinical and histopathologic presentation was consistent with DCS. After failure to improve with numerous oral/topical antibiotics and topical/intra-lesional corticosteroid therapies, the patient achieved an excellent clinical response to oral isotretinoin. The treatment of DCS remains a challenge for dermatologists due to the lack of standardized, evidence-based guidelines. Given the complexity of treating DCS, especially in the pediatric population, raising awareness for effective management options may lead to enhanced patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.